This multi-center project aims to quantify the socio-medical costs associated with Unilateral Spatial Neglect (USN) resulting from acquired brain injury (stroke) and to measure the effects of USN rehabilitation on functional autonomy, quality of life and psychological well-being of patients affected by this syndrome, considering the repercussions on a psychological level and on the quality of life of caregivers. To this end, the experimenters will administer to right brain-injured patients - with (Experimental Group) or without (Control Group) USN - who undertook a rehabilitation process, a series of questionnaires: Activities of daily living (ADL), Barthel Index; Instrumental activities of daily living scale (I-ADL:), the Health Related Quality of Life questionnaire (EQ-5D-5L), the Geriatric Depression Scale (GDS), and the State-Trait Anxiety Inventory (STAI-Y). The aforementioned tests will be administered before the start of the rehabilitation (baseline) and after one month, 3, 6 and 12 months after the end of the rehabilitation. The impact of USN and its treatment on the psycho-physical well-being of the caregiver will be measured through the Caregiver Burden Inventory questionnaire, which will be administered with the same timing (baseline, 1-3-6-12 months after rehabilitation). The costs of USN will be surveyed through an ad-hoc questionnaire, which includes a version intended for patients and one for caregivers, in order to identify the resources consumed due to the disease and the expenses taken during the observation period, to be estimated subsequently in monetary terms (€).
Age range
18 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in the Activities of Daily Living scale (ADL)
Timeframe: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Instrumental Activities of Daily Living scale (I-ADL)
Timeframe: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Health-Related Quality of Life (EQ-5D-5L)
Timeframe: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Geriatric Depression Scale (GDS)
Timeframe: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the State-Trait Anxiety Inventory (STAI-Y)
Timeframe: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Change in the Caregiver Burden Inventory questionnaire (CBI)
Timeframe: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment
Financial impact of USN
Timeframe: 1 month after the end of the treatment
Financial impact of USN
Timeframe: 3 months after the end of the treatment
Financial impact of USN
Timeframe: 6 months after the end of the treatment
Financial impact of USN
Timeframe: 12 months after the end of the treatment